Metformin-Induced Lactic Acidosis Associated with Acute Renal Failure

American Journal of Nephrology

Volumn 16, Issue 6, 1996, Pages 520-522

  Safadi, Rifaat ^a   Dranitzki Elhalel, Michal ^b   Popovtzer, Mordecai ^b   Ben Yehuda, Arie ^a  

^a Division of Medicine   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Lactic acidosis; Metformin; Renal failure; Urea cycle

Indexed keywords

CONTRAST MEDIUM; CREATININE; METFORMIN; ORAL ANTIDIABETIC AGENT; UREA;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; ATHEROSCLEROSIS; CASE REPORT; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HUMAN; KIDNEY DISEASE; LACTIC ACIDOSIS; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL;

ACIDOSIS, LACTIC; AGED; ARTERIOSCLEROSIS; BLOOD UREA NITROGEN; CONTRAST MEDIA; CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; KIDNEY FAILURE, ACUTE; METFORMIN;

EID: 0029958295     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000169052     Document Type: Article

References (13)

1. Nattrass M. Alberti KGMM: Biguanides. Dia-betologia 1978:14:71-74.
2. Arieft AL: Pathogenesis of lactic acidosis. Diabetes Metab Rev 1989:5:627-649.
3. 14C-labeled betaphcnethylbiguanide. Diabetes 1960;9:163-166.
4. Davidoff F: Guanidine derivatives in medicine. N Engl J Med 1973:289:141-146.
5. Hermann LS. Melander A: Biguanides: Basic aspects and clinical uses; in Alberti KGMM. DeFronzo RA. Keen H, Zimmel P (eds): Textbook of Diabetes Mellitus. New York. Wiley, 1992, pp 773-795.
6. Assan R. Heuclin C. Girard JR: Phenformin-induced lactic acidosis in diabetic patients. Diabetes 1975;24:791-800.
7. Kriesberg R. Wood B: Drug- and chemical-induced metabolic acidosis. J Clin Endocrinol Mctab 1983:12:391-411.
8. Bergman U. Boman G. Wiholm B-F.: Epidemiology of adverse drug reactions to phenformin and metformin. Br Med J 1978:ii:464-466.
9. Arieff AL, Park R. Leach WJ. Lazarowitz VC: Pathophysiology of experimental lactic acidosis in dogs. Am J Physiol 1980;239:F135-F142.
10. Eichclboum M. Spannbrucker N, Stiencke B. Dengler HJ: Defective N-oxidation of sparteine in man: A new pharmacogenetic defect. Eur J Clin Pharmacol 1979:16:183-187.
11. Oates NS. Shah RR, Idle JR. Smith RL: Influence of oxidation polymorphism on phcn-formin kinetics and dynamics. Clin Pharmacol Ther 1983:34:827-834.
12. Evans DA, Harmcr D, Downham DY. Whib-ley EJ. Idle JR, Ritchie J. Smith RL: The genetic control of sparteine and debrisoquinc metabolism in man with new methods of analysing bimodal distributions. J Med Genet 1983:20: 321-329.
13. Gudcr WG: Renal and hepatic nitrogen metabolism in systemic acid-base regulation. J Clin ChemClin Biochem 1987;25:457-466.